Results 231 to 240 of about 69,085 (277)

Highly sensitive profiling somatic mutations of thyroid cancer by nucleotide-enrichment-based MALDI-TOF MS assay. [PDF]

Sci Rep
Bai H, Li Y, Li J, Liu T, Xiao J, Xia L, Sun X, Cheng W.   +7 more
europepmc   +1 more source

Bioequivalence centres in Africa: current state and opportunities for growth. [PDF]

J Pharm Policy Pract
Ncube BM, Muthuri S, Ajose O, Kikwai L.
europepmc   +1 more source

Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma. [PDF]

J Exp Clin Cancer Res
Betti M, Accetta C, Arteni BAM, Rosselli A, Melucci E, Visca P, Botti C, Pelle F, Russillo M, Ferraresi V, Migliano E, Cerro M, Scalera S, De Nicola F, Matteoni S, Covino D, Guerrisi A, Pallocca M, Fanciulli M, Pescarmona E, Blandino G, Mancini R, Falcone I, Di Martino S.   +23 more
europepmc   +1 more source

Prenatal Fetal Neurocutaneous Melanosis: A Case Report and Literature Review. [PDF]

Mol Genet Genomic Med
Zhao X, Wang J, Song J, He Y, Zhang X, Ma Q, Gu Y, Lin L.   +7 more
europepmc   +1 more source

Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma. [PDF]

Pigment Cell Melanoma Res
Tellenbach FL, Seiler L, Johnson M, Rehrauer H, Schukla P, Martinez-Gomez J, Stoffel CI, Kamal A, Dummer R, Levesque MP, Eichhoff OM.   +10 more
europepmc   +1 more source

RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors. [PDF]

Mol Cancer Res
Baars B, Orive-Ramos A, Emmett MJ, Gaire B, Desaunay M, Kou Z, Li G, Adamopoulos C, Aaronson SA, Wang S, Sellers WR, Martin T, Gavathiotis E, Poulikakos PI.   +13 more
europepmc   +1 more source

Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy. [PDF]

Cell Oncol (Dordr)
Yang M, Schell MJ, Salk JJ, Higgins J, Hipp M, Pflieger L, Pledger WJ, Yeatman TJ.   +7 more
europepmc   +1 more source

Clinical Significance and Potential Molecular Mechanisms of Angiotensin-Converting Enzyme 2 in Colorectal Cancer. [PDF]

World J Oncol
Zeng DT, Yang L, Wen JY, Wu KJ, Chen GQ, Li ZY, Ling JW, Huang BB, Xie YY, Dong YY, Fang YY, Wei DM, Chen G, Shi L, Huang WJ.   +14 more
europepmc   +1 more source

Genetic diversity in melanomagenesis: a comprehensive analysis of BRAF, NRAS, KIT and novel mutations across melanoma subtypes. [PDF]

BMC Cancer
Göze ÖF, Buettner R, Odenthal M, Heydt C.   +3 more
europepmc   +1 more source